CORALVILLE, IA – July 14 2009. Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, expands its PrimeTime qPCR portfolio to include new assay scales that enable more affordable gene expression studies. The PrimeTime Mini (100 reactions), Standard (500 reactions) and XL (2500 reactions) Assay scales better reflect customer needs for validation and screening studies.
Stephen Gunstream, IDT’s OEM Business Unit Leader commented, “Our new qPCR scales ensure that all scientists, including those who only require limited reactions, can have access to the most precise quantitative PCR chemistry available.”
The new assays can be ordered through IDT’s RealTime PCR Design Tool. The tool allows for ultimate design flexibility and includes the option to select specific exon spanning sites, as well as review all primer and probe sequences prior to purchase.
For more information on IDT’s PrimeTime product offerings, please visit their website at www.idtdna.com/primetime.
About IDT
Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT’s primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com.
